Status:
COMPLETED
Tuberculosis Immunity in Children
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Tuberculosis
Eligibility:
All Genders
1+ years
Brief Summary
The purpose of this study is to gain a better understanding of how immunity to tuberculosis (TB) is maintained in children. When children get tuberculosis, it is more likely to spread to other parts o...
Detailed Description
Tuberculosis (TB) is the number one cause of infectious morbidity and mortality worldwide accounting for 8 million cases and 3 million deaths annually. The impact of TB on children is particularly dev...
Eligibility Criteria
Inclusion
- Children:
- Diagnosed with latent Mtb infection (LTBI), localized tuberculosis (TB), or disseminated TB.
- Age less than or equal to 10 years.
- Adults:
- Diagnosed with localized TB or LTBI.
- All individuals with LTBI will be healthy.
- Individuals with localized TB will have been treated for TB for at least 1 month.
Exclusion
- Older children 11-17 years old.
- Children who are immunocompromised.
- Immunocompromised adults.
- Pregnant women.
- Non-English or non-Spanish speaking individuals.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
End Date :
April 1 2010
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00170638
Start Date
April 1 2005
End Date
April 1 2010
Last Update
April 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health Sciences University
Portland, Oregon, United States, 97239